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Abstract
ENZY CARBOPLUS® is an additive available in liquid and solid forms that contains endo-1,4-beta-
xylanase and endo-1,3(4)-beta-glucanase which are produced by two genetically modiﬁed strains of
Komagataella pastoris. The Panel on Additives and Products or Substances used in Animal Feed
(FEEDAP) concluded that the production strains are safe and the genetic modiﬁcations raise no safety
concerns. The Panel also concluded that the additive is safe for the target species at the
recommended dosages and that its use as a feed additive raises no concern for consumers. The
additive in either form is not a skin or eye irritant nor a dermal sensitiser; however, it is considered as
a potential respiratory sensitiser. The production strains and their recombinant DNA were not
detectable in the additive; moreover, the active substances of the additive will be degraded/inactivated
during passage through the digestive tract of animals or in the environment, consequently, the
Panel concluded that the additive poses no concerns to the environment. The Panel concluded that the
additive has a potential to be efﬁcacious as a zootechnical additive in chickens for fattening at
4,000 LXU and 375 LGU per kg feed, in turkeys for fattening at 1,400 LXU and 120 LGU per kg feed,
and in weaned piglets at 700 LXU and 60 LGU per kg feed. The Panel extended these conclusions to
chickens reared for laying and turkeys reared for breeding at the corresponding doses. Since the mode
of action of xylanase and glucanase can be reasonably assumed to be the same within avian or within
porcine species, the Panel extrapolated the conclusions on the efﬁcacy to all avian species up to the
point of lay and to all porcine species. Owing to the lack of data, no conclusions could be drawn on
the efﬁcacy of the additive in laying hens.
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Summary
Following a request from the European Commission, the Panel on Additives and Products or
Substances used in Animal Feed (FEEDAP) was asked to deliver a scientiﬁc opinion on the safety and
the efﬁcacy of ENZY CARBOPLUS® (endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase) as a feed
additive for avian species, weaned piglets and minor weaned porcine species.
ENZY CARBOPLUS® is a feed additive that presents endo-1,4-beta-xylanase and endo-1,3(4)-beta-
glucanase which is available in solid and liquid form. The enzymes present in the product are produced
by two genetically modiﬁed strains of Komagataella pastoris. The species K. pastoris is considered by
the European Food Safety Authority (EFSA) to be suitable for the qualiﬁed presumption of safety (QPS)
approach to establishing safety for the target species, consumers and the environment. The
production strains were identiﬁed and were considered safe. The genetic modiﬁcations raised no safety
concerns. The strains and their recombinant DNA were not detected in the ﬁnal product.
The results of the tolerance studies showed no negative effects in chickens and turkeys for
fattening, laying hens and in weaned piglets. The Panel concluded that the additive is safe for chickens
for fattening, turkeys for fattening and laying hens at the dose of 1,400 LXU and 120 LGU/kg feed and
safe for weaned piglets at the dose of 700 LXU and 60 LGU/kg feed. The conclusion was extended to
chickens reared for laying and turkeys raised for breeding at the level of 1,400 LXU and 120 LGU/kg
feed. The safety of the additive was shown in major poultry and porcine species with a wide margin of
safety. Therefore, the FEEDAP Panel extrapolated the conclusions to all avian species (1,400 LXU and
120 LGU/kg feed) and to minor porcine species for growing (700 LXU and 60 LGU/kg feed).
The toxicological studies are not required if the fermentation products are produced by a
genetically modiﬁed microorganism that is considered by EFSA to qualify for the QPS approach to
safety assessment and the genetic modiﬁcation raises no concerns. The production strains belong to a
species that is considered to qualify for the QPS approach to safety assessment provided that the
identity is unambiguously established. The identity of the production strains was established and the
genetic modiﬁcations raised no concerns. Therefore, the FEEDAP Panel concluded that the use of ENZY
CARBOPLUS® as a feed additive raises no concern for consumers.
The additive in either form is not a skin or eye irritant nor a dermal sensitiser. Owing to the
proteinaceous nature of the active substance, the additive is considered as a potential respiratory
sensitiser.
Neither the production strains nor their recombinant DNA were detectable in the ﬁnal product.
Moreover, the active substances of the additive are proteins, and as such will be degraded/inactivated
during passage through the digestive tract of animals or in the environment. Consequently, the
additive does not raise concerns for the environment.
The results of the efﬁcacy studies showed that the additive has a potential to be efﬁcacious as a
zootechnical additive in chickens for fattening at 4,000 LXU and 375 LGU per kg feed, in turkeys for
fattening at 1,400 LXU and 120 LGU per kg feed, and in weaned piglets at 700 LXU and 60 LGU per
kg feed. Owing to the lack of data, no conclusions could be drawn on the efﬁcacy of the additive in
laying hens. The Panel extended the conclusions reached in chickens and turkeys for fattening to
chickens raised for laying and turkeys reared for breeding at the corresponding doses. Since the mode
of action of xylanase and glucanase is well known and can be reasonably assumed to be the same
within avian species or within porcine species, the Panel extrapolated the conclusions from turkeys for
fattening to all avian species up to the point of lay and the conclusions from weaned piglets to all
porcine species (in the category of weaned piglets).
ENZY CARBOPLUS® for avian species and weaned piglets
www.efsa.europa.eu/efsajournal 3 EFSA Journal 2017;15(12):5097
Table of contents
Abstract................................................................................................................................................. 1
Summary............................................................................................................................................... 3
1. Introduction............................................................................................................................... 5
1.1. Background and Terms of Reference............................................................................................ 5
1.2. Additional information................................................................................................................. 5
2. Data and methodologies ............................................................................................................. 5
2.1. Data.......................................................................................................................................... 5
2.2. Methodologies............................................................................................................................ 5
3. Assessment................................................................................................................................ 6
3.1. Characterisation ......................................................................................................................... 6
3.1.1. Characterisation of the production organisms ............................................................................... 6
3.1.1.1. Information related to production strain Komagataella pastoris DSM 25376 .................................... 6
3.1.1.2. Information related to production strain Komagataella pastoris DSM 26469 .................................... 7
3.1.2. Manufacturing process................................................................................................................ 7
3.1.3. Characterisation of the additive ................................................................................................... 7
3.1.4. Stability and homogeneity........................................................................................................... 8
3.1.5. Conditions of use ....................................................................................................................... 9
3.2. Safety ....................................................................................................................................... 9
3.2.1. Safety of the genetic modiﬁcation................................................................................................ 9
3.2.2. Safety for the target species ....................................................................................................... 9
3.2.2.1. Safety for chickens for fattening .................................................................................................. 9
3.2.2.2. Safety for turkeys for fattening.................................................................................................... 10
3.2.2.3. Safety for laying hens................................................................................................................. 10
3.2.2.4. Safety for weaned piglets ........................................................................................................... 11
3.2.2.5. Conclusions on safety for the target species ................................................................................. 12
3.2.3. Safety for the consumer ............................................................................................................. 12
3.2.4. Safety for the user ..................................................................................................................... 13
3.2.4.1. Conclusions on safety for the user ............................................................................................... 13
3.2.5. Safety for the environment ......................................................................................................... 13
3.3. Efﬁcacy ..................................................................................................................................... 13
3.3.1. Efﬁcacy for chickens for fattening ................................................................................................ 13
3.3.2. Efﬁcacy for turkeys for fattening.................................................................................................. 14
3.3.2.1. Short-term trials ......................................................................................................................... 14
3.3.2.2. Long-term trials ......................................................................................................................... 15
3.3.3. Efﬁcacy for laying hens ............................................................................................................... 16
3.3.4. Efﬁcacy for piglets ...................................................................................................................... 16
3.3.5. Conclusions on efﬁcacy for the target species............................................................................... 17
3.4. Post-market monitoring............................................................................................................... 18
4. Conclusions................................................................................................................................ 18
Documentation provided to EFSA ............................................................................................................ 18
References............................................................................................................................................. 19
Abbreviations ......................................................................................................................................... 19
Annex A – Executive Summary of the Evaluation Report of the European Union Reference Laboratory for
Feed Additives on the Methods of Analysis for ENZY CARBOPLUS®............................................................. 20
ENZY CARBOPLUS® for avian species and weaned piglets
www.efsa.europa.eu/efsajournal 4 EFSA Journal 2017;15(12):5097
1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 4(1) of that Regulation lays down that any
person seeking authorisation for a feed additive or for a new use of a feed additive shall submit an
application in accordance with Article 7.
The European Commission received a request from Kaesler Nutrition GmbH2 for authorisation of the
product ENZY CARBOPLUS® (endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase), when used as
a feed additive for chickens for fattening and reared for laying, turkeys for fattening and reared for
breeding, laying hens, weaned piglets, minor weaned porcine (e.g. warthogs), avian species (game
birds, ducks, geese, pigeons, sporting and ornamental birds), including laying birds (category:
zootechnical additives; functional group: digestibility enhancers).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 4(1)
(authorisation of a feed additive or new use of a feed additive). EFSA received directly from the
applicant the technical dossier in support of this application. The particulars and documents in support
of the application were considered valid by EFSA as of 27 August 2013.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment and on the efﬁcacy of the
product ENZY CARBOPLUS® (endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase), when used
under the proposed conditions of use (see Section 3.1.5).
1.2. Additional information
ENZY CARBOPLUS® is an additive that presents endo-1,4-beta-xylanase and endo-1,3(4)-beta-
glucanase activities that has not been authorised in the European Union (EU). The enzymes present in
the product are produced by two genetically modiﬁed strains of Komagataella pastoris (DSM 25376
and DSM 26469). The species K. pastoris is considered by EFSA to be suitable for the qualiﬁed
presumption of safety (QPS) approach to establishing safety for the target species, consumers and the
environment (EFSA, 2007EFSA, 2008b; EFSA BIOHAZ Panel, 2017); this approach requires the identity
of the strain to be established.
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier3 in support of the authorisation request for the use of ENZY CARBOPLUS® as a feed additive. The
technical dossier was prepared following the provisions of Article 7 of Regulation (EC) No 1831/2003,
Regulation (EC) No 429/20084 and the applicable EFSA guidance documents.
EFSA has veriﬁed the European Union Reference Laboratory report as it relates to the methods
used for the control of the ENZY CARBOPLUS® in animal feed. The Executive Summary of the
European Union Reference Laboratory report can be found in Annex A.5
2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of ENZY
CARBOPLUS® is in line with the principles laid down in Regulation (EC) No 429/2008 and the relevant
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Kaesler Nutrition GmbH, Zeppelinstrasse 3, 27472 Cuxhaven, Germany.
3 FEED dossier reference: FAD-2013-0013.
4 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
5 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/jrcsh/files/FinRep-FAD-2013-0013-EnzyCarb
oplus.doc_.pdf
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guidance documents: Guidance on zootechnical additives (EFSA FEEDAP Panel, 2012a), Technical
guidance: Tolerance and efﬁcacy studies in target animals (EFSA FEEDAP Panel, 2011), Technical
Guidance for assessing the safety of feed additives for the environment (EFSA, 2008a), Guidance for
establishing the safety of additives for the consumer (EFSA FEEDAP Panel, 2012b), Guidance on
studies concerning the safety of use of the additive for users/workers (EFSA FEEDAP Panel, 2012c),
Technical Guidance: Extrapolation of data from major species to minor species regarding the
assessment of additives for use in animal nutrition (EFSA, 2008b), Technical Guidance: Microbial
Studies (EFSA, 2008c) and the Guidance on the risk assessment of genetically modiﬁed
microorganisms and their products intended for food and feed use (EFSA GMO Panel, 2011).
3. Assessment
ENZY CARBOPLUS® is a feed additive that contains endo-1,4-beta-xylanase (Enzyme Commission
number 3.2.1.8; xylanase) and endo-1,3(4)-beta-glucanase (Enzyme Commission number 3.2.1.6;
glucanase) and is intended to be used as a zootechnical additive (functional group: digestibility
enhancers) in chickens for fattening and reared for laying, turkeys for fattening and reared for
breeding, laying hens, weaned piglets, minor weaned porcine and minor avian species.
3.1. Characterisation
3.1.1. Characterisation of the production organisms
The xylanase and the glucanase present in the additive are produced by two genetically modiﬁed
strains of K. pastoris (formerly named as Pichia pastoris), deposited at the German Collection of
Microorganisms and Cell Cultures (DSMZ) with the accession numbers DSM 25376 and DSM 26469,
respectively.6
3.1.1.1. Information related to production strain Komagataella pastoris DSM 25376
Characteristics of the recipient or parental microorganism7
The recipient strain is K. pastoris GS115. This species is considered by EFSA to be suitable for the
QPS approach for safety assessment (EFSA, 2007; EFSA BIOHAZ Panel et al., 2017). Its genome has
been fully sequenced (De Schutter et al., 2009). The identity of the strain was conﬁrmed by analysis of
the ITS sequences of the ribosomal operons.8
The synthetic Xyn-CDBFV gene, encoding xylanase,9 is based on the xylanase gene of the fungus
Neocallimastix patriciarum. The encoded amino acid sequence differs from the native one in seven
amino acids10 (Chen et al., 2001).
Description of the genetic modiﬁcation process
The synthetic Xyn-CDBFV sequence, without the predicted signal peptide, was ampliﬁed by
polymerase chain reaction (PCR), generating a product of circa 700 bp. This product was ligated into
plasmid pPIC9 after digestion with the restriction enzymes EcoR I and Not I. Plasmid pPIC9 is a
derivative of pBR322 and contains an ampicillin resistance gene. Plasmid pPIC9 also carries the a-MF
signal peptide for protein secretion, a selectable marker for growth of transformed K. pastoris on a
histidine-deﬁcient medium, and both extremes from the alcohol oxidase gene (AOX1) to enable the
replacement of the original AOX gene with the Xyn-CDBFV xylanase gene by homologous
recombination. The resulting plasmid pPIC9-xylanase was maintained in Escherichia coli.
Plasmid pPIC9-xylanase (8.7 kb) was puriﬁed from E. coli and digested with the restriction
endonuclease BglII. A 6.3 kb fragment, containing the Xyn-CDBFV xylanase gene, the extremes of the
AOX1 gene, and the his4 gene used as a selectable marker, was gel-puriﬁed and introduced by
electroporation into K. pastoris GS115. By means of homologous recombination (double crossover),
the AOX1 construct of K. pastoris GS115 was replaced by the recombinant expression cassette,
resulting in the production strain K. pastoris DSM 25376. The integrity of the recombinant DNA and its
chromosomal insertion were conﬁrmed by PCR.
6 Technical dossier/Section II/Annex II.2.1.2.8.
7 This section has been modiﬁed according to the conﬁdentiality claim made by the applicant.
8 Technical dossier/Section II/Annex II.2.1.2.1.
9 Technical dossier/Section II/Annex II.2.1.2.2.
10 Technical dossier/Section II/Annex II.2.1.2.3.
ENZY CARBOPLUS® for avian species and weaned piglets
www.efsa.europa.eu/efsajournal 6 EFSA Journal 2017;15(12):5097
Southern analysis showed that K. pastoris DSM 25376 contains a single copy of the recombinant
gene.11 The absence of the ampicillin resistance gene from plasmid pPIC9 in the genomic DNA of the
production strain was demonstrated by Southern analysis.12 Genetic stability was conﬁrmed by
Southern analysis targeting the recombinant xylanase gene.12
K. pastoris DSM 25376 differs from its parental strain in the ability to produce xylanase and to grow
in the absence of histidine in the culture medium. Microscopic analyses and various physiological tests,
including response to different antimycotics, revealed no other difference between the recipient and
the production strain.13
3.1.1.2. Information related to production strain Komagataella pastoris DSM 26469
This strain was also constructed from the recipient strain K. pastoris GS115 (see Section 3.1.1.1).
Characteristics of the inserted sequences
The synthetic glucanase gene was based on the gene present in Paenibacillus sp. F-40 (CGMCC
1775).6
Description of the genetic modiﬁcation process
The glucanase sequence, without the predicted signal peptide, was ampliﬁed by PCR, generating a
product of ca. 650 bp. This product was ligated into plasmid pPIC9, after digestion with the restriction
enzymes EcoR I and Not I. The resulting plasmid pPIC9-glucanase was maintained in E. coli JM109.
Plasmid pPIC9-glucanase (ca 8.7 kb) was puriﬁed from E. coli JM109 and digested with the
restriction endonuclease BglII. A ca. 6.3 kb fragment, containing the glucanase gene, both extremes
of the AOX1 gene, and the his4 gene used as a selectable marker, was gel-puriﬁed and introduced by
electroporation into K. pastoris GS115. By means of homologous recombination (double crossover),
the endogenous AOX1 construct of K. pastoris GS115 was replaced by the recombinant expression
cassette, resulting in the production strain K. pastoris DSM 26469. The integrity of the recombinant
DNA and its chromosomal insertion were conﬁrmed by PCR.
Southern analysis showed that K. pastoris DSM 26469 contains a single copy of the recombinant
gene.10 The absence of the ampicillin resistance gene from plasmid pPIC9 in the genomic DNA of the
production strain was demonstrated by Southern analysis.12 Genetic stability was conﬁrmed by
Southern analysis targeting the recombinant glucanase gene.12
K. pastoris DSM 26469 differs from its parental strain in the ability to produce glucanase and to
grow in the absence of histidine in the culture medium. Microscopic analyses and various physiological
tests, including response to different antimycotics, revealed no other difference between the recipient
and the production strain.13
3.1.2. Manufacturing process14
The two enzymes are produced separately following the same process. The enzymes are produced
by submerged fermentation with the respective production strain. The fermentation broths are
concentrated-puriﬁed afterwards and the resulting products are used to formulate the ﬁnal
formulations.
3.1.3. Characterisation of the additive
The additive is available in solid, ENZY CARBOPLUS®, and liquid form, ENZY CARBOPLUS® L. The
two ensure a minimum of 25,000 xylanase units (LXU)15 and 2,200 glucanase units (LGU)16 per gram
of product.
ENZY CARBOPLUS® contains the enzyme (1.5%) and 88.5% of (corn) starch and 10% moisture.
The study of the batch-to-batch variation in ﬁve batches showed a mean value of xylanase and
glucanase of 25,627 LXU and 2,301 LGU per gram, respectively, ranging from 25,100/2,243 (xylanase/
11 Technical dossier/Section II/Annex II.2.1.2.4.
12 Technical dossier/Supplementary information April 2014.
13 Technical dossier/Section II/Annex II.1.4.1.2.
14 This section has been amended following the provisions of Article 8(6) and Article 18 of Regulation (EC) No 1831/2003.
15 LXU: one xylanase unit is the amount of enzyme that releases one µmole of reducing sugar equivalents per minute (as xylose
from birch xylan) at pH 5.5 and 50°C.
16 LGU: one glucanase unit is the amount of enzyme which liberates one µmole of reducing sugar equivalents per minute (as
glucose from barley glucan) at pH 5.5 and 50°C.
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glucanase) to 26,112/2,360 (coefﬁcient of variation (CV) 1.6% and 1.7% for xylanase and glucanase,
respectively).17 The study of the particle distribution in three batches (laser diffraction) showed that
particles below 100 lm amount 80% and particles below 10 lm amount 5%.18 Dusting potential
measured by the Stauber–Heubach test was 5.07 g/m3.19
ENZY CARBOPLUS® L contains the enzyme 1.5% (w/w), 15% of glycerol, 5% of sodium chloride,
0.30% of sodium benzoate, 0.15% potassium sorbate and water up to 100%. The study of the batch-
to-batch variation in ﬁve batches showed a mean value of xylanase and glucanase of 25,912 LXU and
2,316 LGU per gram ranging from (xylanase/glucanase) 25,100/2,216 to 26,860/2,420 (CV 3.4% and
3.6% for xylanase and glucanase, respectively).20 The speciﬁc weight of the formulation is 10.816–
10.881 kN/m3 and the viscosity ranges 3.79–4.17 mPas (at 25°C).21
Three batches of the ﬁnal formulations were analysed for chemical and microbial contamination.22
Chemical contamination included the analysis of lead (< 0.91 mg/kg in the solid and < 0.50 mg/kg in the
liquid), cadmium (< 0.20 mg/kg), mercury (< 0.02 mg/kg) and arsenic (< 2.38 mg/kg in the solid and
< 0.50 mg/kg in the liquid) and dioxins and dioxin-like PCBs (WHO-PCDD/F-PCB TEQ, < 0.32 ng/kg). The
following mycotoxins were analysed: aﬂatoxins (B1, B2, G1 and G2, < 1.0 lg/kg), zearalenone
(< 37.0 lg/kg in the solid and < 5.0 lg/kg in the liquid), ochratoxin A (< 0.20 lg/kg), HT-2 toxin and T2
toxin (< 10.0 lg/kg).The study of the microbial contamination included of E. coli (< 10 colony forming
units/g) and Salmonella spp. (absence in 25 g).
The absence of antimycotic activity was proven in concentrated supernatant of culture of the
production strains using Candida albicans EELA 188.13 Antimicrobial activity was studied23 in yeast broth
cultures (10-fold concentrated) and in the liquid enzyme preparation (ﬁvefold concentrated, three
batches) by using ﬁve bacterial strains Pseudomonas aeruginosa ATCC 27853, Enterococcus faecalis
ATCC 29212, E. coli ATCC 25922, Staphylococcus aureus ATCC 25923 and Bacillus subtilis ATCC 6633
(EFSA, 2008c). The substances tested showed no antimicrobial activity.
No cultivable cells of the production strains were detected in three batches of 30 mL (liquid) or 1 g
(solid) product, by incubation in liquid and solid non-selective media at 30°C for 96 h under conditions
supporting the growth of K. pastoris.13 No recombinant DNA was detected in 200 lL samples of three
independent batches of the liquid form, by quantitative PCR, targeting DNA fragments of 79–80 bp of
the xylanase gene and 91–92 bp of the glucanase gene.13 Since the two formulations of the additive
share a common manufacturing process, the results obtained in the liquid form apply also to the solid.
3.1.4. Stability and homogeneity
The batches of the additive used in the studies provided in this section had a different ratio
xylanase:glucanase (range from 1 to 7) compared to the one speciﬁed for the additive (similar to 11).
However, it is considered that this different ratio would not have an impact on the results of the
stability of the enzymes contained in the product.
The shelf-life of the solid formulation was studied in three batches stored in closed containers at
25°C for 24 months or at 40°C for 6 months.24 Recovery values for the two enzymes were > 80% in
the two conditions tested. Another study was provided in three batches of the solid formulation stored
at 20°C for one month. Recovery values were higher than 95%.25
The shelf-life of the liquid formulation was studied in three batches stored in closed containers at
5°C for 24 months or at 25°C for 6 months.24 Recovery values were > 90% for xylanase at either
temperature. For glucanase, the values after 24 months stored at 5°C showed a 65% recovery and
80% recovery after 6 months stored at 25°C.
The stability of three batches of the solid formulation was evaluated in a vitamin mineral premixture
containing choline chloride stored at 25°C for 6 months under standard conditions in a small paper bag
with an inside polyethylene coating.24 The supplementation was of 45,000 LXU and 7,250 LGU/kg
17 Technical dossier/Section II/Annex II.1.3.1.
18 Technical dossier/Section II/Annex II.1.5.1.
19 Technical dossier/Section II/Annex II.1.5.2.
20 Technical dossier/Section II/Annex II.1.3.2.
21 Technical dossier/Supplementary information April 2014/Annex II.1.5.4.
22 Technical dossier/Supplementary information April 2014/Annex II.1.4.1.5.
23 Technical dossier/Supplementary information April 2014/Annex II.1.4.1.6 and Supplementary information May 2015/Annex
II.1.4.1.8.
24 Technical dossier/Supplementary information March 2014/Annex II.4.1.1.
25 Technical dossier/Supplementary information May 2017.
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premixture. After the 6-month storage period, the recovery for xylanase was higher than 84% and for
glucanase higher than 87%.
The stability in feed was studied for three batches of the solid formulation added to mash and
pelleted feed and for three batches of the liquid formulation added to pelleted feed.24 Samples of the
feeds were stored for three months at 25°C. Recovery values were > 95% in all cases. The data also
permitted to study the stability of the enzymes during pelleting which was of 90% for xylanase and of
70% for glucanase.
Homogeneity of the distribution of the enzyme activities was studied in the vitamin mineral
premixture in the feeds used for the stability studies by analysing 10 subsamples of each premixture/
feed. The coefﬁcient of variation was below 8% in all cases.
3.1.5. Conditions of use
The applicant proposes the additive to be added to the feed for avian species at the recommended
enzyme activity of 1,400 LXU and 120 LGU/kg feed (56 mg additive per kg feed) and in feed for weaned
piglets (including minor species) at 700 LXU and 60 LGU/kg feed (28 mg additive per kg feed).
3.2. Safety
3.2.1. Safety of the genetic modiﬁcation
The parental strain belongs to a species K. pastoris, which is considered by EFSA to be suitable for the
QPS approach for safety assessment when used for enzyme production (EFSA BIOHAZ Panel, 2017). The
production strains harbour one copy of the Xyn-CDBFV xylanase gene (K. pastoris DSM 25376), and one
copy of a glucanase gene (K. pastoris DSM 26469), respectively. In addition, both strains carry a gene
enabling growth in the absence of histidine. None of the introduced genes raises safety concern.
Neither the viable production strains nor their recombinant DNA were found in the ﬁnal products.
The product ENZY CARBOPLUS®, manufactured by fermentation with K. pastoris DSM 25376 and DSM
26469 strains, does not give rise to safety concern with regard to the genetic modiﬁcation.
3.2.2. Safety for the target species
Tolerance trials in chickens and turkeys for fattening, laying hens and weaned piglets were submitted.
The test item in the studies below reported was not the additive but a diluted form obtained by mixing
the solid formulation of the additive with starch. The enzyme activities in the test items used were
measured for each study and were close to 8,400 LXU and 775 LGU per gram (2.9 times dilution). The
Panel considers this test item as acceptable and will refer to it as the additive. Some of the studies miss
the information on the glucanase activity in the feeds. However, this can be estimated from the data on
the xylanase activity in feed and the enzyme activities present in the test item used in each study.
In all the studies the signiﬁcance level in the statistical evaluation was set at 0.05.
3.2.2.1. Safety for chickens for fattening
A total of 432 one-day-old male chicks (Ross 308) were distributed randomly to 48 cages in groups
of nine birds and allocated to three dietary treatments (representing 16 replicates per treatment).26
Starter and grower diets based on wheat, rye and soya bean meal were either not supplemented
(control) or supplemented with the additive to provide xylanase/glucanase at 2,100/180 (1.59
recommended dose) or 21,000/1,800 (159) LXU/LGU per kg feed. Xylanase and glucanase were
analysed (100/2,300, 4,120/2,683 and 30,300/4,739).27 The feed was offered to the birds ad libitum in
mash form for 35 days. Health of the animals was monitored daily and feed consumption and body
weight were measured on days 1, 14 and 35 of the study. At the end of the study blood samples were
obtained from 15 birds per treatment (sampled from 15 different cages) and analysed for biochemical28
and haematological29 parameters. An analysis of variance (ANOVA) was done with the data obtained
(including treatment and block as effects), group means were compared with Duncan test.
26 Technical dossier/Section III/Annex III.1.1.1 and Supplementary information April 2014.
27 Technical dossier/Supplementary information April 2014/Annex II.4.1.2.
28 Including: total protein, urea, cholesterol, glutamate dehydrogenase, aspartate aminotransferase, gamma glutamyl
transpeptidase, bilirubin, calcium, inorganic P, beta-hydroxybutyrate.
29 Including: erythrocytes, haematocrit, haemoglobin, mean corpuscular volume, mean corpuscular haemoglobin, red cell
distribution width, mean corpuscular haemoglobin and white blood cells differential.
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Mortality was low (< 3.5%) and not affected by the dietary treatments. Mean daily feed intake was
93 g, ﬁnal body weight 2.2 kg and feed to gain ratio was 1.56. The ﬁnal body weight was higher and
the feed to gain ratio lower in the groups treated with the additive compared to the control (see
efﬁcacy section for details, trial 1). There were no signiﬁcant differences between groups for the
parameters evaluated in blood. Supplementation of the experimental diets with 15-fold the
recommended dose (1,400 LXU and 120 LGU/kg feed) did not have negative effects on the birds.
3.2.2.2. Safety for turkeys for fattening
A total of 336 one-day-old male turkeys (Big 7) were distributed randomly in 48 cages in groups
of seven birds and allocated to three dietary treatments (representing 16 replicates per treatment).30
A basal diet, based on wheat and soya bean meal was either not supplemented (control) or
supplemented with the additive to provide xylanase/glucanase at 2,100/180 (1.59 recommended dose)
or 21,000/1,800 (159) LXU/LGU per kg feed. Glucanase was not analysed, xylanase was measured in
the feeds and found to be higher than the intended dosages (< 100, 3,900 and 44,533).12 The feed
was offered to the birds ad libitum as mash for 42 days. Health of the animals was monitored daily and
feed consumption and body weight were measured on days 1 and 42 of the study. Blood samples were
obtained from 15 birds per treatment (one per cage with the exception of one cage) and analysed for
biochemical31 and haematological32 parameters. An ANOVA was performed with the data obtained).
Mortality was low (< 2%) and not affected by the dietary treatments. No signiﬁcant differences
were observed in the performance of the birds. Mean daily feed intake was 76 g/bird, ﬁnal body
weight 1.89 kg, average daily gain was 44 g and feed to gain ratio 1.76. Regarding the blood
parameters, the groups receiving the additive had lower blood urea (4.9 vs 3.6 mg/dL for control and
supplemented groups, respectively) and inorganic phosphate (11.0 vs 9.8 mg/dL) compared to the
control. These differences in blood urea and inorganic phosphate are considered of little biological
relevance. Overall, the supplementation of the experimental diets with 15-fold the recommended dose
did not have negative effects on the turkeys.
3.2.2.3. Safety for laying hens
Two studies in laying hens were submitted.
In the ﬁrst study, a total of 222 18-week-old Hy-Line hens were individually caged and allocated to
three dietary treatments (representing 74 individual hens per treatment).33 A basal diet based on
triticale, rye, wheat and soya bean meal was either not supplemented (control) or supplemented with
the additive to provide (xylanase/glucanase), 2,100/180 (1.59) or 21,000/1,800 (15x) LXU/LGU per kg
feed (conﬁrmed by analysis for xylanase 115, 2,450 and 22,100 LXU/kg). Glucanase was not
analysed.12 Feed was offered ad libitum and in mash form for 70 days (1–10 week laying period).
Body weight was measured at the beginning and at the end of the study. Health, feed intake and
laying performance were monitored/recorded throughout the study. Eggs were weighed every two
weeks and egg quality parameters were measured on 15 eggs per treatment on weeks 4, 8 and 10 of
study. At the end of the experiment, blood samples from 15 hens per treatment, randomly selected,
were collected in order to analyse them for biochemical34 and haematological35 parameters. An ANOVA
was done with the data.
No hens died and no differences were noted on the body weight of the hens or in their feed intake
(mean value 118 g/day per hen). Total number of eggs (55.8, 58.6, 55.9 for 0/0, 1.59 and 159,
respectively), egg mass produced (3.37 kg, 3.53 and 3.33) and feed to egg mass (2.51, 2.42 and
2.61) were better in the 1.59 group compared to 159 group. The results in the 159 group did not
differ to those of the control. Egg quality parameters showed no modiﬁcations. No signiﬁcant
differences were identiﬁed in the blood parameters measured.
30 Technical dossier/Section III/Annex III.1.1.5.
31 Including: total protein, urea, cholesterol, glutamate dehydrogenase, aspartate aminotransferase, gamma glutamyl
transpeptidase, bilirubin, calcium, inorganic P.
32 Including: erythrocytes, haematocrit, haemoglobin, leucocytes, thrombocytes, mean corpuscular volume, mean corpuscular
haemoglobin, red cell distribution width, white blood cells differential.
33 Technical dossier/Section III/Annex III.1.1.2 and Supplementary information April 2014.
34 Total protein, blood urea, cholesterol, glutamate dehydrogenase, aspartate aminotransferase, gamma-glutamil-transpeptidase,
bilirubin, calcium and inorganic phosphate.
35 Red blood cells, haemoglobin, haematocrit, leucocytes, segmented neutrophils, lymphocytes, monocytes, eosinophils,
basophils, thrombocytes, mean corpuscular volume, mean corpuscular haemoglobin, mean corpuscular haemoglobin
concentration and red cell distribution width.
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In the second study, a total of 90 25-week-old Lohmann-Brown hens were penned in groups of ﬁve
hens and allocated to three dietary treatments (representing six replicates per treatment).36 A basal
diet based on maize, rye and soya bean meal was either not supplemented (control) or supplemented
with the additive to provide (xylanase/glucanase) 2,100/180 (1.59) or 21,000/1,800 (159) LXU/LGU
per kg feed. The results of the analysis of xylanase < 200, 1,360 and 10,625 LXU/kg, showed that the
1.5 and 159 dosage were not reached, in fact they represented 1x and 8x. Glucanase was not
measured.12 Feed was offered in mash form for 56 days. Body weight was measured at the beginning
and at the end of the study. Health, feed intake and laying performance were monitored/recorded
throughout the study. At the end of the experiment, blood samples from 10 hens (one or two hens per
replicate) were collected in order to analyse them for biochemical37 and haematological38 parameters.
An ANOVA was applied to the data.
No hen died and no signiﬁcant differences were identiﬁed on the body weight, feed intake (mean
value 109 g/day), total number of eggs (54.5) nor in the egg mass produced (3.3 kg). The feed to
egg mass ratio (1.88, 1.83, 1.81 for 0/0, 1.5x and 15x) was better in the 159 group as compared to
control. No differences were found in the blood parameters measured with the exception of sodium
which was signiﬁcantly higher in the treated hens compared to control but the increase can be
considered of no biological relevance (149 vs 153 mmol/L).
The results of these two studies showed that the supplementation of the experimental diets up to
15-fold the recommended dose did not have negative effects on the laying hens.
3.2.2.4. Safety for weaned piglets
The applicant submitted two trials, in the ﬁrst, a total of 1,487 male and female weaned piglets
(PIC, 6.5 kg body weight, 24 days old) were distributed in a total of 50 ﬂoor pens in groups of 26–34
piglets and allocated to ﬁve dietary treatments (10 replicates per treatment).39 Prestarter and starter
diets, based on maize, wheat, barley and soybean meal, were supplemented with the additive to provide
xylanase/glucanase at 0/0, 700/60 (19 recommended dose), 1,400/120, 2,100/180, 21,000/1,800
(309) kg feed. Enzyme activities were conﬁrmed by analysis40 (87/1028, 599/1,273, 1,033/1,330,
1,763/1,523, 18,325/4,476). The feed was offered in mash (prestarter) or pelleted (starter) form and
ad libitum for 42 days. Body weight and feed intake were measured on day 14 and day 42 of the study
(body weight was also measured at the beginning). On day 42, blood was collected from 15 animals of
each experimental group for biochemical measurements.41 No haematological parameters were
analysed on the blood samples. An ANOVA was done on the data obtained and mean groups were
compared with Duncan test.
Mortality was low (2.5%) and not related to the treatments. Final weight (23.8 kg), daily weight
gain (413 g/day) and feed to gain ratio (1.52) were signiﬁcantly improved in groups receiving the
additive compared to control animals (for details, see efﬁcacy trial 2). Blood chemistry parameters
showed no differences between treatments. This trial was done considering 30-fold the recommended
dose and lacked the measurements on the haematological parameters. Therefore, the applicant
submitted a second trial.
In the second trial,42 a total of 60 female and castrated male weaned piglets (Large
White 9 Landrace, initial body weight of 7.5 kg, 25 days old) were penned in groups of two and
allocated to three dietary treatments (representing 10 replicates per treatment). Starter and grower
diets basal diets, based on wheat, barley, rye and soya bean meal were either not supplemented
(control) or supplemented with the additive to provide xylanase/glucanase at 2,500/220 (3.59
recommended dose) or 25,000/2,200 (359) LXU/LGU per kg feed. Xylanase and glucanase were
analysed in the feeds (128/153, 1,275/863 and 17,175/5,200). The feed was offered to the piglets
ad libitum in mash form for 42 days. Health of the animals was monitored twice daily, feed
consumption and body weight were measured weekly and feed to gain ratio was calculated. At the
36 Technical dossier/Section III/Annex III.1.1.3 and Supplementary information April 2014.
37 Sodium, potassium, chloride, calcium and phosphorus, total cholesterol, triglycerides, bilirubin, uric acid, glucose, albumin,
total protein, alanine amino transferase, aspartate amino transferase and alkaline phosphatase.
38 Red blood cells, haemoglobin, haematocrit, leucocytes, neutrophils, lymphocytes, monocytes, eosinophils, basophils, mean
corpuscular volume, mean corpuscular haemoglobin and mean corpuscular haemoglobin concentration.
39 Technical dossier/Section III/Annex III.1.1.4 and Supplementary information April 2014/Annex II.4.1.2.
40 Glucanase was measured only in the starter diet.
41 Including: total protein, blood urea, cholesterol, glutamate dehydrogenase, non-esteriﬁed fatty acids, aspartate
aminotransferase, gamma-glutamyl transferase, bilirubin, calcium, phosphorus and lactate dehydrogenase.
42 Technical dossier/Supplementary information April 2015/Annex III.1.1.7.
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end of the study, blood samples were obtained from 10 pigs per treatment (one per pen) and
analysed for biochemical43 and haematological44 parameters. An ANOVA was done with the data
obtained.
No animals died. Total feed intake per pig was not different between the treatments (30 kg/pig).
Final body weight of the piglets was 28.4, 29.4 and 29.9 kg for 0, 3.59 and 359, respectively, and the
corresponding ﬁgures for feed to gain ratio was 1.48, 1.39 and 1.35. The ﬁnal body weight in the
35-fold group was higher than in the control. Regarding the blood parameters there were no signiﬁcant
differences between groups except a signiﬁcant increase in the mean corpuscular haemoglobin
concentration in the animals receiving the 35-fold group compared to the other groups (29 vs 32 g/dL).
This modiﬁcation although signiﬁcant is considered of little biological relevance.
Overall, the supplementation of the experimental diets up to 35-fold the recommended dose did
not have negative effects on the weaned piglets.
3.2.2.5. Conclusions on safety for the target species
The FEEDAP Panel concludes that the additive is safe for chickens for fattening, turkeys for
fattening, laying hens and weaned piglets at the corresponding recommended levels (1,400 LXU and
120 LGU/kg feed for chickens and turkeys for fattening and laying hens and 700 LXU and 60 LGU/kg
feed for piglets). The conclusion on the safety in chickens and turkeys for fattening can be extended
to chickens reared for laying and turkeys reared for breeding, respectively.
The safety of the additive has been shown in major poultry species/categories and weaned piglets
with a margin of safety higher than ten-fold the recommended dose. Considering that the additive is
proposed to be used at the same levels in other avian and porcine species the safety for the latest can
be presumed without the need for speciﬁc studies. Therefore, the FEEDAP Panel concludes that the
conclusions regarding the safety can be extrapolated to all avian species at 1,400 LXU and 120 LGU/kg
and to minor porcine species (growing stages) at 700 LXU and 60 LGU/kg feed.
3.2.3. Safety for the consumer
Toxicological studies are not required if the fermentation products are produced by a genetically
modiﬁed microorganism for which the recipient strain is considered by EFSA to qualify for the QPS
approach to safety assessment and for which the genetic modiﬁcation does not give raise to concerns.
The enzymes present in the additive are produced by two genetically modiﬁed strains of K. pastoris;
this species is considered to qualify for the QPS approach to safety assessment for enzyme production
provided that the identity is unambiguously established. The identity of the production strains was
established. Moreover, the genetic modiﬁcations to which the strains were subject raised no concerns.
Therefore, the fermentation products obtained from these two strains are considered safe for the
consumers.
The applicant provided various toxicity studies conducted with the ﬁnal liquid formulation to support
the safety of the product: three genotoxicity studies and a subchronic oral toxicity study. The results of
a bacterial reverse mutation assay,45 an in vitro mammalian cell micronucleus test46 and an in vivo
comet assay in the rat47 showed no evidence for genotoxic potential. In the subchronic oral toxicity
study in rats,48 no treatment-related effects were reported. These studies can be considered as added
evidence of the safety of the product.
Considering the above and the composition of the additive, the FEEDAP Panel concludes that the
use of ENZY CARBOPLUS® as a feed additive raises no concern for consumers.
3.2.4. Safety for the user
No speciﬁc tests were provided to study the effects on the respiratory system. Owing to the
proteinaceous nature of the active substance, the additive is considered as a potential respiratory
43 Including: sodium, potassium chloride, calcium, inorganic phosphate, alanine amino transferase, aspartate amino transferase,
alkaline phosphatase, total cholesterol, triglycerides, urea, bilirubin, glucose, albumin and total protein.
44 Including: erythrocytes, leukocytes, thrombocytes, white blood cells differential, haemoglobin, haematocrit, mean corpuscular
volume, mean corpuscular haemoglobin, mean corpuscular haemoglobin concentration.
45 Technical dossier/Section III/Annex III.2.2.2.1.
46 Technical dossier/Section III/Annex III.2.2.2.2.
47 Technical dossier/Section III/Annex III.2.2.2.3.
48 Technical dossier/Section III/Annex III.2.2.3.
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sensitiser. Considering the high dusting potential of the solid formulation (5.07 g/m3) and the
percentage of particle below 10 lm (5%), there is a potential for exposure by inhalation.
The effects on the skin and eyes were investigated with the two ﬁnal formulations. The data
included acute dermal49 and eye50 irritation studies in the rabbit which were performed according to
OECD Guideline 404 or OECD Guideline 405, respectively. Results showed that the additive in either
form is not irritant to skin or eye. Moreover, skin sensitisation studies in the guinea pig were performed
according to OECD Guideline 406.51 Results showed that the additive in either form is not a dermal
sensitiser.
3.2.4.1. Conclusions on safety for the user
The additive in either form is not a skin or eye irritant nor a dermal sensitiser. Owing to the
proteinaceous nature of the active substance, the additive is considered as a potential respiratory
sensitiser.
3.2.5. Safety for the environment
The production strains and their recombinant DNA were not detected in the ﬁnal product. The
active substances of the additive are proteins, and as such will be degraded/inactivated during
passage through the digestive tract of animals or in the environment. Therefore, the additive does not
pose concerns to the environment.
3.3. Efﬁcacy
The test item in the studies below reported was not the additive but a diluted form obtained by
mixing the solid formulation of the additive with starch. The enzyme activities in the test items used
were measured for each study and was close to 8,900 LXU and 750 LGU per gram (2.9 times dilution).
The Panel considers this test item as acceptable and will refer to it as the additive. Some of the studies
miss the information on the glucanase activity in the feeds. However, this can be estimated from the
data on the xylanase activity in feed and the enzyme activities present in the test item used in each
study. In all the studies the signiﬁcance level in the statistical evaluation was set at 0.05.
3.3.1. Efﬁcacy for chickens for fattening
Four long-term trials were considered (three efﬁcacy trials and the tolerance trial). In one of the
efﬁcacy trials,52 the birds were caged in groups of two animals until day 21 of life. At that point, one
of the animals per cage was removed from the study. This fact leaves as the only reliable parameter
the body weight of the birds that remained under study, further to this fact, the Panel considers that
the removal of the animals may bias the outcome of the study. Consequently, this trial was not
considered further.
For the other trials, the details on the study design are provided in Table 1 and the main results in
Table 2.
In all trials, 1-day-old male birds were used and the birds were fed either a non-supplemented diet
(control) or a diet supplemented with the additive to provide different enzymes concentrations.
Xylanase was analysed in all studies, glucanase was measured only in trial 1. The diets were
administered from day 1 of life until day 35 of life. The health and mortality were monitored
throughout the study and the body weight and feed intake were recorded. Feed to gain ratio was
calculated. The data was analysed with an ANOVA, using the pen as the experimental unit. Group
means were compared with Duncan test in trial 1 and 3 and Student–Newman–Keuls test in trial 2.
In trial 1, the body weight and the feed to gain ratio were signiﬁcantly improved at the dose of
2,100 LXU and 180 LGU per kg feed. The analysis of the diets revealed a higher enzyme activity in the
feed than the intended one (dose of 3,600 LXU and 410 LGU per kg feed). In the other two trials,
birds fed the dose of 700 LXU and 60 LGU, or above, showed a signiﬁcantly better feed to gain ratio
(in trial 2) or a higher ﬁnal body weight in trial 3.
49 Technical dossier/Section III/Annexes III.3.1.2.3 and III.3.1.2.4.
50 Technical dossier/Section III/Annexes III.3.1.2.1 and III.3.1.2.2.
51 Technical dossier/Section III/Annexes III.3.1.2.5 and III.3.1.2.6.
52 Technical dossier/Section IV/Annex IV.3.1 Supplementary information April 2014/Annex IV.3.1 and Annex II.4.1.2 and
Supplementary information April 2015 IV.3.1.addendum.
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Therefore, three studies showed an improvement of the performance of the birds, two at the level
of 700 LXU and 60 LGU per kg feed and a third study at an analysed level of 4,011 LXU and 374 LGU
per kg feed. Therefore, the Panel considers that the additive has a potential to be efﬁcacious at a level
similar to 4,000 LXU and 375 LGU per kg feed (delivered by ca 165 mg of additive per kg feed).
The Panel notes that the efﬁcacious enzyme activities in chickens for fattening are higher than the
recommended by the applicant. The conclusions on the tolerance were drawn based on the
recommendation made by the applicant, however, the enzyme activities tested, parameters measured
and the results obtained in the tolerance trial allow the Panel to consider that 4,000 LXU and 375 LGU
per kg feed is safe for chickens for fattening.
3.3.2. Efﬁcacy for turkeys for fattening
Two short-term trials and three long-term trials were submitted.
3.3.2.1. Short-term trials
Two balance trials were provided. In the ﬁrst, a total of 72 one-day-old male turkeys (BUT Big 6)
were kept in groups of six birds and allocated to three dietary treatments from day 0 to 28 of life.53
Table 1: Trial design and dosages of the efﬁcacy trials performed in chickens for fattening
Trial
Total no of animals
(animals 3 replicate)
replicates 3 treatment
Breed sex
(duration)
Composition
feed (form)
Enzyme activity
(LXU/LGU per kg feed)
Intended Analysed(a)
1(b) 432
(9)
16
Ross 308
Males
(35 days)
Wheat, rye soya bean
meal (pellets)
0/0
2,100/180
21,000/1,800
–/–
4,011/373
30,195/2,429
2(c) 769
(12–13)
16
Ross 308
Males
(35 days)
Wheat, rye, soya bean
meal (pellets)
0/0
700/60
1,400/120
2,100/180
< 200/–
847/–
1,715/–
2,882/–
3(d) 3,600
(60)
60
Ross 308
Males
(35 days)
Wheat, rye, soya bean
meal (crumble/pellets)
0/0
700/60
1,400/120
2,100/180
< 200/–
532/–
1,214/–
2,156/–
(a): The enzyme activity present in the control diet was subtracted from the supplemented feeds.
(b): Technical dossier/Section III/Annex III.1.1.1.
(c): Technical dossier/Section IV/Annex IV.3.2 and supplementary information April 2014/Annex II.4.1.2.
(d): Technical dossier/Section IV/Annex IV.3.3 and supplementary information April 2014/Annex II.4.1.2.
Table 2: Effects of ENZY CARBOPLUS® on the performance of chickens for fattening
Trial
Enzyme activity
(LXU/LGU per kg feed)
Daily feed intake
(g/bird)
Final body
weight (g)
Feed to
gain ratio
Mortality and
culling (%)
1 0/0
2,100/180
21,000/1,800
93
95
91
2,110b
2,223a
2,178a
1.58a
1.52b
1.50b
3.5
1.4
2.8
2 0/0
700/60
1,400/120
2,100/180
98a
93b
93b
93b
1,943
1,955
1,957
1,974
1.76a
1.67b
1.66b
1.64b
1.02
2.58
0.51
2.05
3 0/0
700/60
1,400/120
2,100/180
101b
106a
106a
106a
2,038b
2,160a
2,167a
2,165a
1.77
1.74
1.73
1.73
0.89
0.55
0.89
0.78
a,b: Mean values within a trial and within a column with a different superscript are signiﬁcantly different p < 0.05.
53 Technical dossier/Supplementary information April 2014/Annex IV.3.10 and supplementary information April 2015.
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On day 28, the birds were transferred to individual balance cages (24 replicates per treatment). In the
second,54 a total of 192 six-day-old male turkeys (Hybrid Converter) were caged in groups of four and
allocated to three dietary treatments (representing 16 replicates per treatment). In the two trials, the
basal diets based on wheat, rye and soya bean meal were either not supplemented (control) or
supplemented with the additive to provide xylanase/glucanase at 700/60 or 1,400/120 LXU/LGU per kg
feed. In the ﬁrst trial, only xylanase was analysed and showed enzyme activities higher than the
intended (70, 1,500 and 4,700 LXU per kg feed). In the second, the analysis conﬁrmed the intended
dosages for the two enzymes (130/< 40, 945/42 and 1,675/86 LXU/LGU per kg feed). A balance study
was performed from days 28 to 36 of life in the ﬁrst balance trial and on days 22–25 in the second.
Total collection of excreta was done. Feed and excreta were analysed for energy content. An ANOVA
was done with the data and group means were compared with Tukey test (trial 1) or Duncan (trial 2).
In the ﬁrst trial, the metabolisable energy content of the diets in turkeys fed the highest dose
(2,100/180 LXU/LGU per kg feed) was signiﬁcantly higher compared to the control group (12.0 vs
11.7 MJ/kg) but not at the lower tested dose (700/60 LXU/LGU per kg feed; 11.8 MJ/kg feed). In the
second trial, the metabolisable energy content of the diets was higher in the birds receiving the
additive at either dose compared to the control (10.08, 10.45 and 10.87 MJ per kg feed for control,
700/60 and 2,100/180 groups, respectively).
3.3.2.2. Long-term trials
The details on the study design of the three long-term trials submitted are provided in Table 3 and
the main results in Table 4. In all trials, one-day-old male birds were used and the birds were fed
either with non-supplemented diet (control) or a diet supplemented with the additive to provide
different enzymes concentrations. All studies included a group with 1,400 LXU and 120 LGU per kg
feed. Xylanase and glucanase were analysed in feeds. The diets were administered for 84 days. The
health and mortality were monitored throughout the study and the body weight and feed intake were
recorded. Feed to gain ratio was calculated. The data was analysed with an ANOVA, using the pen as
the experimental unit and group means were compared with Tukey test.
The results in trial 1 showed no differences in any of the parameters studied between the different
groups. In trial 2, a higher body weight and a better feed to gain ratio were found in the birds
receiving 1,400 LXU and 120 LGU per kg feed. In trial 3, a better feed to gain ratio of the birds was
found at the same level.
Table 3: Trial design and dosages of the efﬁcacy trials performed in turkeys for fattening
Trial
Total no of animals
(animals 3 replicate)
replicates 3 treatment
Breed sex
(duration)
Composition
feed (form)
Enzyme activity
(LXU/LGU per kg feed)
Intended Analysed(a)
1(b) 900
(75)
4
Big 6
Male
(84 days)
Wheat, rye, soya
bean meal (pellets)
0/0
700/60
1,400/120
–/–
372/140
789/251
2(c) 1,280
(20)
16
BUT 8
Male
(84 days)
Wheat, soya bean
meal (mash)
0/0
700/60
1,400/120
2,100/180
–/–
705/90
1,800/121
2,710/247
3(d) 945
(33–34)
7
Big 6
Male
(84 days)
Wheat, rye, soya
bean meal
(crumble/pellets)
0/0
700/60
1,400/120
2,100/180
–/–
550/41
1,301/101
2,360/140
(a): The enzyme activity present in the control diet was subtracted from the supplemented feeds.
(b): Technical dossier/Section IV/Annex IV.3.6 and Supplementary information April 2014/Annex IV.3.6 and Annex II.4.1.2.
(c): Technical dossier/Section IV/Annex IV.3.7 and Supplementary information April 2014/Annex II.4.1.2.
(d): Technical dossier/Section IV/Annex IV.3.8 and Supplementary information April 2014/Annex II.4.1.2.
54 Technical dossier/Supplementary information April 2015/Annex IV.3.11.
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Based on the results of one short-term trial (second balance trial) and of two long-term trials
(second and third), the FEEDAP Panel concludes that the additive has a potential to be efﬁcacious as a
zootechnical additive in turkeys for fattening at 1,400 LXU and 120 LGU per kg feed.
3.3.3. Efﬁcacy for laying hens
Four short-term trials were submitted, three of them were not considered further due to the nature
of the parameters measured.55 In these three digestibility studies, several parameters were measured
including laying performance, egg quality parameters, digestibility (ash, crude protein, crude fat, crude
ﬁbre) but the effect of the additive on the metabolisable energy content of the diets was not studied.
Consequently, these studies cannot be considered to support the efﬁcacy of the additive.
The fourth short-term trial56 was conducted with 60 Lohmann-Brown layers 24 weeks old were
caged in groups of two and distributed to three dietary treatments (10 replicates per treatment). A
basal diet (Gross energy content ~ 17 MJ/kg feed) based on rye and soya bean meal was either not
supplemented (control) or supplemented with the additive to provide xylanase/glucanase 700/60 or
1,400/120 LXU/LGU per kg feed. Xylanase and glucanase were analysed: 605/293 and 1,700/600
(unsupplemented diet values subtracted). The feed was offered ad libitum from week 24 to 28 in mash
form and contained titanium dioxide. Laying performance of the hens was measured and on the last
week samples of ileal and excreta were collected. A balance study was performed on the last three
days of the study. Feed and excreta samples were analysed for different parameters including the
energy. An ANOVA was done with the data and the mean groups were compared with Tukey test.
The results of the balance trial showed higher energy retention in the groups fed the enzymes
compared to control (84% vs 79%), leading to a higher metabolisable energy content of the diets
(13.2 MJ/kg feed in the control and 14.9 and 14.4 MJ/kg feed in the 700/60 and 1,400/120 LXU/LGU
per kg feed groups, respectively. Laying performance was not different between the groups.
Evidence of efﬁcacy was provided in one trial, therefore the Panel considers that the information
provided is insufﬁcient to conclude on the efﬁcacy of the additive in laying hens.
3.3.4. Efﬁcacy for piglets
A total of four long-term trials were submitted. One trial57 was not considered further because of
the high mortality (8.7%) and culling (5.6%).
For the three studies considered, the details on the study design are provided in Table 5 and the
main results in Table 6. In the three trials, the treatment groups included a group with 700 LXU and
60 LGU per kg feed. The two enzyme activities in feed were analysed in trials 1 and 2 (glucanase only
in the starter diet, not in prestarter), in trial 3 only xylanase was measured. The piglets received the
feeds for 42 days. Feed intake and body weight of the piglets was measured and feed to gain ratio
Table 4: Effects of ENZY CARBOPLUS® on the performance of turkeys for fattening
Trial
Enzyme activity
(LXU/LGU per kg feed)
Feed intake(1)
(kg)
Final body
weight (kg)
Feed to
gain ratio
Mortality
(%)
1 0/0
700/60
1,400/120
0.224
0.226
0.227
8.17
8.40
8.49
2.33
2.28
2.27
4.0
4.7
4.0
2 0/0
700/60
1,400/120
2,100/180
18.5
18.6
18.6
18.7
8.37c
8.45bc
8.48b
8.59a
2.21a
2.20ab
2.19bc
2.17c
5.0
2.8
5.3
3.8
3 0/0
700/60
1,400/120
2,100/180
0.252
0.252
0.248
0.244
10.35
10.30
10.41
10.36
2.03a
2.02a
1.97b
1.98b
2.9
1.3
2.1
0.4
(1): For trial 1 and 3, the feed intake is daily feed intake per bird and for trial 2 it is total feed intake per bird.
a,b,c: Mean values within a trial and within a column with a different superscript are signiﬁcantly different p < 0.05.
55 Technical dossier/Section IV/Annexes IV.2.1, IV.2.2 and IV.2.4.
56 Technical dossier/Section IV/Annex IV.2.3 and supplementary information April 2014/Annex IV.2.3_amendment.
57 Technical dossier/Section IV/Annex IV.3.4 and Supplementary information April 2014/Annex II.4.1.2.
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was calculated. The data was analysed with an ANOVA, using the pen as the experimental unit and
group means were compared with Tukey test in trials 1 and 3 and with Duncan test in trial 2.
The three long-term trials considered showed no or a low mortality rate. In all three trials, the feed
to gain ratio was signiﬁcantly better in the piglets receiving the enzymes from 700 LXU and 60 LGU
per kg feed and onwards. Therefore, the additive has a potential to be efﬁcacious as a zootechnical
additive in weaned piglets at 700 LXU and 60 LGU per kg feed.
3.3.5. Conclusions on efﬁcacy for the target species
The additive has a potential to be efﬁcacious as a zootechnical additive in chickens for fattening at
4,000 LXU and 375 LGU per kg feed, in turkeys for fattening at 1,400 LXU and 120 LGU per kg feed
and in weaned piglets at 700 LXU and 60 LGU per kg feed. The conclusions reached in chickens for
fattening and turkeys for fattening can be extended to chickens raised for laying and turkeys reared
for breeding at the corresponding levels.
The Panels notes that the efﬁcacious level in chickens for fattening is higher than the one
recommended by the applicant. The conclusions on the tolerance were drawn based on the
recommended level, however, the enzyme activities tested, parameters measured and the results
Table 5: Trial design and dosages of the efﬁcacy trials performed in weaned piglets
Trial
Total no of animals
(animals 3 replicate)
replicates 3 treatment
Age (days)
at start (sex)
Composition
feed (form)
Enzyme activity
(LXU/LGU per kg feed)
Intended Analysed(a)
1(b) 120
(2)
15
28 (Females and
castrated males)
Wheat, barley, rye and
soya bean meal
(pellet)
0/0
700/60
1,400/120
2,100/180
–/–
466/8
1,061/38
1,664/69
2(c) 1,487
(26–34)
10
24 (Females and
castrated male)
Maize, wheat and
barley (pelleted/mash)
0/0
700/60
1,400/120
2,100/300
21,000/3,000
–/–
513/122
947/151
1,677/248
17,726/3,203
3(d) 144
(6)
8
25 (females and
males)
Wheat, barley, rye and
soya bean meal
(mash)
0/0
700/60
1,400/120
–/–
690/–
1,450/–
(a): The enzyme activity present in the control diet was subtracted from the supplemented feeds.
(b): Technical dossier/Section IV/Annex IV.3.5 and Supplementary information April 2014/Annex II.4.1.2.
(c): Technical dossier/Section IV/Annex III.1.1.4 and Supplementary information April 2014/Annex II.4.1.2.
(d): Technical dossier/Supplementary information April 2014/Annex IV.3.9.
Table 6: Effects of ENZY CARBOPLUS® on the performance of weaned piglets
Trial
Enzyme activity
(LXU/LGU per kg feed)
Feed
intake(1)
Body weight (kg) Feed to
gain ratio
Mortality
(%)Initial Final
1 0/0
700/60
1,400/120
2,100/180
544
548
550
540
8.5
8.5
8.5
8.5
22.4
23.7
23.4
23.2
1.64a
1.52b
1.55b
1.56b
0
0
0
0
2 0/0
700/60
1,400/120
2,100/300
21,000/3,000
616
612
629
645
609
6.5
6.6
6.4
6.4
6.3
22.7c
23.6bc
24.3ab
25.0a
23.4bc
1.62a
1.51b
1.49b
1.47b
1.52b
3.5
1.6
1.8
2.5
3.0
3 0/0
700/60
1,400/120
30.8
31.0
30.8
6.7
6.7
6.6
26.4
27.7
27.7
1.57a
1.48b
1.46b
0
0
0
(1): For trial 1 and 2, the feed intake is daily feed intake per piglet (g) and for trial 3 it is total feed intake per piglet (kg).
a,b,c: Mean values within a trial and within a column with a different superscript are signiﬁcantly different p < 0.05.
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obtained in the tolerance trial allow the Panel to consider that 4,000 LXU and 375 LGU per kg feed is
safe for chickens for fattening.
No conclusions can be drawn on the efﬁcacy of the additive in laying hens due to the lack of data.
Since the mode of action of xylanase and glucanase is well known and can be reasonably assumed
to be the same within avian species or within porcine species, the Panel extrapolates the conclusions
drawn on the efﬁcacy in turkeys for fattening to all avian species up to the point of lay and the
conclusions drawn in weaned piglets to all porcine species (in the category of weaned piglets). No
conclusions can be drawn on the efﬁcacy of the product in minor poultry species for laying.
3.4. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation58 and Good
Manufacturing Practice.
4. Conclusions
The production strains are considered safe and the genetic modiﬁcations raise no safety concerns.
The strains and their recombinant DNA were not detected in the ﬁnal product.
The additive is safe for chickens for fattening, turkeys for fattening, laying hens and weaned piglets
at the levels proposed by the applicant (1,400 LXU and 120 LGU/kg feed for avian species and
700 LXU and 60 LGU/kg feed for pigs). The conclusion can be extended to chickens reared for laying
and turkeys for fattening at the same dose. The conclusions from the major species can be
extrapolated to all avian species at the dose of 1,400 LXU and 120 LGU/kg and to minor porcine
species (weaned piglets) at the dose of 700 LXU and 60 LGU/kg feed.
The use of ENZY CARBOPLUS® as a feed additive raises no concerns for consumers of food
products derived from animals fed with the additive.
The additive in either form is not a skin or eye irritant nor a dermal sensitiser but is considered as a
potential respiratory sensitiser.
The use of ENZY CARBOPLUS® as a feed additive is of no concern for the environment.
The additive has a potential to be efﬁcacious as a zootechnical additive in chickens for fattening at
4,000 LXU and 375 LGU per kg feed, in turkeys for fattening at 1,400 LXU and 120 LGU per kg feed,
and in weaned piglets at 700 LXU and 60 LGU per kg feed. The conclusions reached in chickens for
fattening and turkeys for fattening can be extended to chickens raised for laying and turkeys reared
for breeding at the corresponding levels. The conclusions on the efﬁcacy from turkeys for fattening
can be extrapolated to all avian species up to the point of lay and the conclusions from weaned piglets
to all porcine species (weaned piglets). The Panel cannot conclude on the efﬁcacy of the additive in
laying hens or minor poultry species for laying.
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Annex A – Executive Summary of the Evaluation Report of the European
Union Reference Laboratory for Feed Additives on the Methods of Analysis
for ENZY CARBOPLUS®
In the current application, authorisation is sought under article 4(1) for ENZY CARBOPLUS® and
ENZY CARBOPLUS® L, under the category/functional 4(a) ‘zootechnical additives’/’digestibility
enhancers’ according to the classiﬁcation system of Annex I of Regulation (EC) No 1831/2003.
Speciﬁcally, authorisation is sought for the use of the feed additive for chickens and turkeys for
fattening, chickens reared for laying, turkeys reared for breeding, laying hens, minor avian species
including laying birds (game birds, geese, pigeons, sporting and ornamental birds), weaned pigs, and
minor weaned porcine (e.g. warthogs).
According to the Applicant, the active agents of the ENZY CARBOPLUS® products are b-xylanase
(EC 3.2.1.8) and b-glucanase (EC 3.2.1.6) produced by fermentation of two genetically modiﬁed yeast
strains Pichia pastoris SUNHY 002 (DSM 25376) and SUNHY 004 (DSM 26469). The xylanase and
b-glucanase enzymatic activities are expressed by the Applicant in LXU and LGU units, respectively.
One LXU or LGU unit is the amount of enzyme which releases one micromole of reducing sugars
equivalents (as xylose or glucose) from birch xylan or barley glucan per minute at pH 5.5 and 50°C.
The product is intended to be marketed in a powder and liquid formulations having a guaranteed
minimum xylanase and b-glucanase activities of 25,000 (LXU/g or LXU/mL) and 2,200 (LGU/g or
LGU/mL). The carrier in the solid formulation is starch, while glycerol, sodium chloride and sodium
benzoate are used for the liquid formulation. The feed additive is intended to be included into
premixtures and/or feedingstuffs with a minimum xylanase activity of 700 or 1,400 LXU/kg and a
minimum b-glucanase activity of 60 or 120 LGU/kg depending on the target specie.
For the determination of xylanase and b-glucanase activities in the feed additive, premixtures and
feedingstuffs, the Applicant submitted two single-laboratory validated and further veriﬁed colorimetric
methods. Both methods are based on the quantiﬁcation of water soluble dyed fragments produced by
the action of the respective enzymes on the appropriate commercially available (Megazyme) cross-
linked substrate. Based on the acceptable performance characteristics, the EURL recommends for
ofﬁcial control the validated and further veriﬁed colorimetric method for the determination of xylanase
and b-glucanase activities in the feed additive, premixtures and feedingstuffs.
Further testing or validation of the methods to be performed through the consortium of National
Reference Laboratories as speciﬁed by Article 10 (Commission Regulation (EC) No 378/2005) is not
considered necessary.
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